Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study
- Conditions
- Chronic Low-back PainInsomniaSleep
- Registration Number
- NCT07008924
- Lead Sponsor
- University of Kansas Medical Center
- Brief Summary
Our goal is to observational study is to determine feasibility of partial sleep restriction in individuals with CLBP+I and correlation findings with features of central sensitization.
* Identify feasibility of sleep restriction protocol
* Identify correlation between less sleep and central sensitization Sleep will be monitored for 2 weeks (baseline sleep monitoring period). Then participants will be asked to restrict their sleep to 80% of their normal sleep duration for 5 nights (sleep restriction period). Then sleep will be monitored again for 2 weeks (sleep recovery period).
- Detailed Description
Actigraph and sleep diaries will be used to record sleep time and quality of sleep for 2 weeks baseline period. During this period several measures for pain, sleep, fatigue, cognition, and psychological status will be completed. Quantitative sensory testing will be used to establish pain threshold. Then, the participants will partial sleep restriction (20% sleep reduction/night for 5 nights). Following the completion of restricted sleep period, all outcome measures related to pain, sleep, fatigue, cognition, and psychological status will be assessed (post-sleep restriction assessment). Then participants' sleep will be monitored for 2-weeks (sleep recovery period). During the 5-night of sleep restriction, participants will be asked to complete electronic daily diary related to sleep, pain, fatigue, psychological distress and physical activity. Potential risk related to less sleep will be clearly explained to all potential individuals interested in participating.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 50
• 25-65 years old individuals
Additional inclusion criteria for individuals with CLBP+I:
- With or without insomnia
- CLBP (LBP for at least 3 months with or without referred or radiating leg pain; pain intensity 1 or greater on 0 - 10 VAS scale
- likely to participate in all scheduled evaluations and study procedures by self-report
- agrees to abide by safely protocol e.g. not to drive or operate heavy machinery and perform heavy labor work, during the sleep-restriction period
- spine compression, tumor, infection, history of spine surgery
- neurological conditions such as stroke, Parkinson's disease, Alzheimer's disease or other cognitive impairments.
- pregnancy
- known untreated sleep disorder (such as current sleep apnea or current restless leg syndrome) screened by the following scales to ensure insomnia symptoms are due to insomnia and not another common sleep disorders:
- Those with increased risk of sleep apnea
- Increased risk of restless leg syndrome on RLS-Diagnosis Index
- Increased risk of circadian rhythm sleep-wake disorder
- Increased risk of parasomnia
- Moderate level of depression identified by Patient Health Questionnaire (PHQ-9)
- Moderate level of anxiety identify by Generalized Anxiety Disorder (GAD-7)
- history of drug or alcohol abuse as defined by DSM-IV criteria within the last 2 years
- severe mental illness such as schizophrenia or bipolar disorder
- developmental history of learning disability or attention-deficit/hyperactivity disorder
- is currently receiving CBT-I, physical therapy or chiropractic treatment
- history of spinal surgery
- current use of blood thinning medications
- resting blood pressure greater than 160/90 mmHg40,49,50
- performs overnight shift work
Additional exclusion criteria for HC individuals:
• pain rating 0 out of 0 - 10 Numeric Rating Pain Scale in any parts of the body
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep Measures Through study completion, up to 5 weeks Pittsburgh Sleep Quality
Pain Measures Through study completion, up to 5 weeks SF-McGill (MPQ),
- Secondary Outcome Measures
Name Time Method Sleep Measures Through study completion, up to 5 weeks Actigraphy- wearable sensor to record sleep quality and duration.
Psychological Measures Through study completion, up to 5 weeks Catastrophizing Scale (PCS)
Daily questionnaire Through study completion, up to 5 weeks For sleep restriction and recovery periods
Pain Measures Through study completion, up to 5 weeks Pinprick assessment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States
University of Kansas Medical Center🇺🇸Kansas City, Kansas, United States